Allergan Aesthetics, an AbbVie company, (NYSE: ABBV) announced today that eight scientific abstracts from its leading portfolio of aesthetic products and treatments will be presented at the American Society for Dermatologic Surgery (ASDS) meeting taking place October 6-10 in Denver. Allergan Aesthetics has one of the largest, most-researched portfolio and pipeline in the medical aesthetics industry. Data presented across a broad spectrum of aesthetic indications aims to further scientific research and improve patient outcomes. “Our scientific excellence continues to help drive advancements in aesthetic medicine, as well bring impactful treatments to our customers and patients globally,” said(…) Read More »

Exit mobile version